{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:10:21Z","timestamp":1760346621622,"version":"3.41.0"},"reference-count":39,"publisher":"Informa UK Limited","issue":"13","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.4155\/bio-2017-0067","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T16:49:47Z","timestamp":1499705387000},"page":"987-1000","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["LC\u2013MS Determination of Triazolam and its Hydroxy Metabolites in Mouse Dried Blood Spots: Application to Transgenic Mouse Pharmacokinetic Studies"],"prefix":"10.1080","volume":"9","author":[{"given":"Prashant","family":"Kole","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore560099, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijith","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore560099, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishwanath","family":"Kurawattimath","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore560099, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandhya","family":"Mandlekar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore560099, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,7,10]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.20506\/rst.33.1.2283"},{"issue":"2","key":"e_1_3_5_4_1","first-page":"139","article-title":"Using dried blood spot sampling to improve data quality and reduce animal use in mouse pharmacokinetic studies","volume":"54","author":"Wickremsinhe ER","year":"2015","unstructured":"Wickremsinhe ER , PerkinsEJ. Using dried blood spot sampling to improve data quality and reduce animal use in mouse pharmacokinetic studies. J. Am. Assoc. Lab. Anim. Sci. 54 (2), 139\u2013144 (2015).","journal-title":"J. Am. Assoc. Lab. Anim. Sci"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-011-0066-5"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-013-1286-y"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.18433\/J3NK60"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.01.002"},{"issue":"1","key":"e_1_3_5_9_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0026-895X(25)09118-7","article-title":"Oxidation of midazolam and triazolam by human liver cytochrome P450 3A4","volume":"36","author":"Kronbach T","year":"1989","unstructured":"Kronbach T , MathysD, UmenoM, GonzalezFJ, MeyerUA. Oxidation of midazolam and triazolam by human liver cytochrome P450 3A4. Mol. Pharmacol. 36 (1), 89\u201396 (1989).","journal-title":"Mol. Pharmacol"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007572803027"},{"issue":"1","key":"e_1_3_5_11_1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-3565(24)37398-7","article-title":"Effects of ketoconazole on triazolam pharmacokinetics, pharmacodynamics and benzodiazepine receptor binding in mice","volume":"285","author":"Fahey JM","year":"1998","unstructured":"Fahey JM , PritchardGA, MoltkeLLet al. Effects of ketoconazole on triazolam pharmacokinetics, pharmacodynamics and benzodiazepine receptor binding in mice. J. Pharmacol. Exp. Ther. 285 (1), 271\u2013276 (1998).","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2008.07.014"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.1130090110"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/15.6.319"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2005.11.016"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2010.01.027"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2012.06.023"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/anatox\/35.3.170"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/29.4.240"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1006\/abio.2001.5203"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(02)00523-X"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/24.3.194"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/34.2.89"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.12.42"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.2013"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2009.02.015"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182947cf8"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.12.269"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2008.11.025"},{"key":"e_1_3_5_30_1","unstructured":"Guideline on Bioanalytical Method Validation . European Medicines Agency London UK (2011). www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdf."},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac020361s"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac802362s"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.10.103"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.13.156"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00798356"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.13.170"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.14.151"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00618781"},{"issue":"2","key":"e_1_3_5_39_1","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0022-3565(24)35332-7","article-title":"Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms","volume":"292","author":"Perloff MD","year":"2000","unstructured":"Perloff MD , von MoltkeLL, CourtMH, KotegawaT, ShaderRI, GreenblattDJ. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms. J. Pharmacol. Exp. Ther. 292 (2), 618\u2013628 (2000).","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/26.1.52"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac5022562"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/bio-2017-0067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:52:56Z","timestamp":1750535576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/bio-2017-0067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":39,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.4155\/bio-2017-0067"],"URL":"https:\/\/doi.org\/10.4155\/bio-2017-0067","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"type":"print","value":"1757-6180"},{"type":"electronic","value":"1757-6199"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-03-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}